EDSA (STOCKS)
Edesa Biotech, Inc. Common Shares
$1.070000
+0.020000 (+1.90%)
Prev close: $1.050000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Pardeep Nijhawan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $8.83M
- Employees
- 16
- P/E (TTM)
- -0.78
- P/B (TTM)
- 2.35
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q4)
|
$-0.32 | $-0.27 | -0.0480 | -17.65% |
|
Jun 2025 (Q3)
|
$-0.25 | $-0.27 | +0.0186 | +6.92% |
|
Mar 2025 (Q2)
|
$-0.30 | $-0.30 | +0.0009 | +0.30% |
|
Dec 2024 (Q1)
|
$-0.48 | $-0.32 | -0.1638 | -51.80% |
Financial Statements
| Nonoperating Income/Loss | $726.84K |
| Research and Development | $3.67M |
| Operating Income/Loss | -$7.91M |
| Income/Loss From Continuing Operations After Tax | -$7.19M |
| Income/Loss From Continuing Operations Before Tax | -$7.18M |
| Income Tax Expense/Benefit | $800.00 |
| Net Income/Loss | -$7.19M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$7.19M |
| Net Income/Loss Available To Common Stockholders, Basic | -$7.19M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.27 |
| Basic Average Shares | 5,676,708 |
| Assets | $13.53M |
| Current Assets | $11.51M |
| Noncurrent Assets | $2.02M |
| Liabilities | $1.08M |
| Current Liabilities | $1.08M |
| Noncurrent Liabilities | $0.00 |
| Equity | $12.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $12.45M |
| Liabilities And Equity | $13.53M |
| Net Cash Flow From Operating Activities | -$7.32M |
| Net Cash Flow From Operating Activities, Continuing | -$7.32M |
| Net Cash Flow From Investing Activities | -$9.71M |
| Net Cash Flow From Investing Activities, Continuing | -$9.71M |
| Net Cash Flow From Financing Activities | $17.03M |
| Net Cash Flow From Financing Activities, Continuing | $17.03M |
| Net Cash Flow | $0.00 |
| Net Cash Flow, Continuing | $0.00 |
| Comprehensive Income/Loss | -$7.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$7.11M |
| Other Comprehensive Income/Loss | -$7.11M |